Neoadjuvant chemotherapy in urothelial bladder cancer: impact of regimen and variant histology.

about

Neoadjuvant chemotherapy in urothelial bladder cancer: impact of regimen and variant histology.

Item

http://www.wikidata.org/entity/Q38859015

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Neoadjuvant chemotherapy in ur ...... regimen and variant histology.

@en

type

Item

label

Neoadjuvant chemotherapy in ur ...... regimen and variant histology.

@en

prefLabel

Neoadjuvant chemotherapy in ur ...... regimen and variant histology.

@en

P1476

Neoadjuvant chemotherapy in ur ...... regimen and variant histology

@en

P2093

Costantine Albany

http://www.w3.org/2001/XMLSchema#string

Hristos Z Kaimakliotis

http://www.w3.org/2001/XMLSchema#string

Jane S Cho

http://www.w3.org/2001/XMLSchema#string

Jose A Pedrosa

http://www.w3.org/2001/XMLSchema#string

K Clint Cary

http://www.w3.org/2001/XMLSchema#string

Liang Cheng

http://www.w3.org/2001/XMLSchema#string

Michael O Koch

http://www.w3.org/2001/XMLSchema#string

Noah M Hahn

http://www.w3.org/2001/XMLSchema#string

Richard Bihrle

http://www.w3.org/2001/XMLSchema#string

Richard S Foster

http://www.w3.org/2001/XMLSchema#string

P2860

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis.

Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy.

Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.

A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience

Which patients benefit the most from neoadjuvant chemotherapy in advanced bladder cancer?

P304

1795-1804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON-2016-0056

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M Francesca Monn

Paul T Gellhaus

P577

2016-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27255805

http://www.w3.org/2001/XMLSchema#string